DrugDesign2013: Fragment and Ligand Based Drug Design is a conference dedicated to developments in experimental and computational approaches to fragment- and ligand-based drug design, including:
- Fragment binding/selectivity
- Computational chemistry/molecular modeling
- Protein-protein/ligand interaction
- Ligand design and binding
- New screening technologies and their practical applications
DrugDesign2013: Fragment and Ligand Based Drug Design brings together:
- Academia: Postdoctoral Scientists, Laboratory Heads/Professors, Advanced Graduate Research Students
- Industry: Reseach Directors, SCO, Senior and Junior Researchers, Team Leaders
